CryoPort Names Michael Bartholomew as Chief Commercialization Officer

LAKE FOREST, Calif.--(BUSINESS WIRE)-- CryoPort, Inc. (OTCBB:CYRX) today announced that it has named Michael Bartholomew as Chief Commercialization Officer. Mr. Bartholomew has 20 years experience in marketing, sales and sales management in the pharmaceuticals and materials industries.

"Michael has an outstanding track record of achieving rapid sales growth and developing business opportunities in the life science industry," said Larry Stambaugh, CryoPort's President and Chief Executive Officer. "He has built high-performance sales organizations for several companies, and we are looking forward to having his knowledge and leadership skills at CryoPort."

Previously, Mr. Bartholomew was Vice President, Sales and Marketing for DDN Pharmaceutical Logistics where he developed and launched several commercial initiatives that achieved sustained sales growth. Prior to that, he was Vice President, Sales and Marketing for Alby Materials, and a Senior Institutional Sales Manager for Pfizer, Inc.

About CryoPort, Inc.

CryoPort ( has developed a leading edge, proprietary, technology-driven transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. The products developed by CryoPort have a 10+ day holding time, are using "green" materials and are essential components of the infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex global logistical environment.

    Source: CryoPort, Inc.